STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: A structured protocol

STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: A structured protocol

Show other versions (1)

<h4>Introduction</h4> Long COVID (LC), the persistent symptoms ≥12 weeks following acute COVID-19, presents major threats to individual and public health across countries, affecting over 1.5 million people in the UK alone. Evidence-based interventions are urgently required and an integra...

Full description

Bibliographic Details
Main Authors: Denise Forshaw, Emma C. Wall, Gordon Prescott, Hakim-Moulay Dehbi, Angela Green, Emily Attree, Lyth Hismeh, William D. Strain, Michael G. Crooks, Caroline Watkins, Chris Robson, Rajarshi Banerjee, Paula Lorgelly, Melissa Heightman, Amitava Banerjee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931100/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931100/?tool=EBI

Similar Items